It was reported that the patient experienced fever and swelling of the legs.A 6x80, 130 cm eluvia drug-eluting vascular stent system was selected for a patient procedure.The stent was implanted in the mid left superficial femoral artery (sfa) on (b)(6) 2019.The patient then complained of fever and swelling of the legs four days later.The procedure was performed from the right common femoral artery by contralateral approach.A non-bsc sheath was advanced to the origin part of the left sfa, and a jupiterfc3 guidewire crossed the lesion.After that, a measurement was performed in the blood vessel with ivus and size selection of a pre-balloon and eluvia was performed.The blood vessel diameter was about 5.8 mm.The pre-balloon used was an unspecified 5mm.After pre-ballooning the lesion, the guidewire was replaced with non-bsc guidewire, and eluvia was placed.There was nothing unusual about the placement.The guidewire was replaced with jupiterfc3, and post-balloon was performed by an unspecified 5mm balloon.The status of the stent was checked by ivus, and the procedure was completed.The physician does not think eluvia is the cause of the fever and swelling of the legs.No further complications were reported.
|